Daniel O. Persky

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy”.

Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy

Blood Advances(2020)10.1182/bloodadvances.2020002297

N/A

0DataRank · unranked

14 citations

Claudia M. Espitia, Daniel O. Persky, Jennifer S. Carew, Steffan T. Nawrocki, Shariful Islam

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma

Viruses(2021)10.3390/v13071406

N/A

0DataRank · unranked

10 citations

Claudia M. Espitia, Daniel O. Persky, Jennifer S. Carew, Steffan T. Nawrocki, Shariful Islam

Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.

PubMed(2024)10.14670/hh-18-644

N/A

0DataRank · unranked

2 citations

Margaret E. Tome, Dean Billheimer, Catherine Spier, Catharine L. Smith, Daniel O. Persky +2 more